![Quiver Logo](/static/img/logo-icon.png)
![RCKTW logo](https://quiver-logos.s3.us-east-2.amazonaws.com/rcktw.png)
Rocket Pharmaceuticals, Inc. Warrant
Rocket Pharmaceuticals Inc is a late-stage biopharmaceutical company. It is focused on the development of gene therapies for rare and devastating pediatric diseases. The pipeline products of the company include RP-A501 for Danaon Disease, RP-L102 for Fanconi Anemia, RP-L201 for Leukocyte Adhesion, RP-L301 for Pyruvate Kinase Deficiency, and RP-L401 for Infantile Malignant Osteopetrosis.
The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.
The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.Sign Up to view RCKTW Smart Score
See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.
Example:
The Bulls Say summary highlights positive aspects of the stock.
The Bears Say summary points out potential risks and negative aspects of the stock.
Recent trades of RCKTW by members of U.S. Congress
Recently reported changes by institutional investors
Quarterly net insider trading by RCKTW's directors and management
Government lobbying spending instances
New patents grants
Federal grants, loans, and purchases
Recent insights relating to RCKTW
Recent picks made for RCKTW stock on CNBC
ETFs with the largest estimated holdings in RCKTW
Flights by private jets registered to RCKTW
![Quiver Logo](/static/img/logo-icon.png)